Lindsey Rolfe
2015
In 2015, Lindsey Rolfe earned a total compensation of $3.1M as EVP of Clinical and Pre-Clinical Development and Pharmacovigilance and Chief Medical Officer at Clovis Oncology.
Compensation breakdown
| Bonus | $57,915 |
|---|---|
| Option Awards | $2,590,701 |
| Salary | $350,409 |
| Other | $71,815 |
| Total | $3,070,839 |
Rolfe received $2.6M in option awards, accounting for 84% of the total pay in 2015.
Rolfe also received $57.9K in bonus, $350.4K in salary and $71.8K in other compensation.
Rankings
In 2015, Lindsey Rolfe's compensation ranked 3,084th out of 13,638 executives tracked by ExecPay. In other words, Rolfe earned more than 77.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,084 out of 13,638 | 77th |
Division Manufacturing | 1,100 out of 5,190 | 79th |
Major group Chemicals And Allied Products | 402 out of 1,854 | 78th |
Industry group Drugs | 315 out of 1,528 | 79th |
Industry Pharmaceutical Preparations | 250 out of 1,182 | 79th |
Source: SEC filing on April 26, 2017.
Rolfe's colleagues
We found five more compensation records of executives who worked with Lindsey Rolfe at Clovis Oncology in 2015.
2015
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
2015
Andrew Allen
Clovis Oncology
Chief Medical Officer
2015
Gillian Ivers-Read
Clovis Oncology
EVP of Technical Operations and Chief Regulatory Officer
2015
Erle Mast
Clovis Oncology
Chief Financial Officer
2015
Steven Hoerter
Clovis Oncology
EVP and Chief Commercial Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019